Moderna, Inc.
MRNANasdaqFull coverage
Price
Loading your watchlists
Balance sheet
For a spreadsheet set to a decimal comma. Applies to Copy table and Download CSV.
USD millions · shares in millions · per-share in USD · share counts not split-adjusted
| Line | Trend | FY 2025Ended Dec 31, | FY 2024Ended Dec 31, | FY 2023Ended Dec 31, | FY 2022Ended Dec 31, | FY 2021Ended Dec 31, | FY 2020Ended Dec 31, | FY 2019Ended Dec 31, | FY 2018Ended Dec 31, | FY 2017Ended Dec 31, | FY 2016Ended Dec 31, |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | |||||||||||
| Restricted cash, current | |||||||||||
| Short-term investments | |||||||||||
| Available-for-sale debt securities, current | |||||||||||
| Receivables, total | |||||||||||
| Accounts receivable | |||||||||||
| Inventories | |||||||||||
| Prepaid expenses and other current assets | |||||||||||
| Prepaid expenses | |||||||||||
| Other current assets | |||||||||||
| Total current assets | |||||||||||
| Property, plant and equipment, including finance lease assets | |||||||||||
| Property, plant and equipment | |||||||||||
| Property, plant and equipment, gross | |||||||||||
| Accumulated depreciation | |||||||||||
| Finance lease right-of-use assets | |||||||||||
| Operating lease right-of-use assets | |||||||||||
| Long-term investments | |||||||||||
| Available-for-sale debt securities, non-current | |||||||||||
| Goodwill | |||||||||||
| Intangible assets | |||||||||||
| Finite-lived intangible assets | |||||||||||
| Deferred tax assets | |||||||||||
| Restricted cash, non-current | |||||||||||
| Other non-current assets | |||||||||||
| Total non-current assets | |||||||||||
| Total assets | |||||||||||
| Accounts payable and accrued liabilities | |||||||||||
| Accounts payable | |||||||||||
| Accrued liabilities | |||||||||||
| Accrued compensation | |||||||||||
| Operating lease liabilities, current | |||||||||||
| Finance lease liabilities, current | |||||||||||
| Deferred revenue | |||||||||||
| Taxes payable | |||||||||||
| Other current liabilities | |||||||||||
| Total current liabilities | |||||||||||
| Long-term debt and finance lease liabilities | |||||||||||
| Long-term debt | |||||||||||
| Finance lease liabilities | |||||||||||
| Operating lease liabilities | |||||||||||
| Deferred tax liabilities | |||||||||||
| Other non-current liabilities | |||||||||||
| Total non-current liabilities | |||||||||||
| Total liabilities | |||||||||||
| Operating lease liabilities, total | |||||||||||
| Finance lease liabilities, total | |||||||||||
| Redeemable (temporary) equity | |||||||||||
| Temporary equity attributable to the company | |||||||||||
| Preferred stock | |||||||||||
| Preferred stock, value issued or outstanding | |||||||||||
| Common stock and paid-in capital | |||||||||||
| Common stock | |||||||||||
| Additional paid-in capital | |||||||||||
| Retained earnings | |||||||||||
| Accumulated other comprehensive income | |||||||||||
| Shareholders' equity | |||||||||||
| Total equity | |||||||||||
| Total liabilities and equity | |||||||||||
| Shares outstanding | |||||||||||
| Preferred shares issued | |||||||||||
| Preferred shares outstanding | |||||||||||
| Preferred stock, par or stated value per share | |||||||||||
Use the arrow keys to move between values, and Enter to see where a value comes from.
Growth
| Line | Q3 2026vs a year earlier | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Revenue | ||||
| Gross profit | ||||
| Diluted EPS | ||||
| Free cash flow | ||||
| Diluted share count |
Margins
| Margin | TTM Q4 2021Ended Dec 31, | TTM Q1 2022Ended Mar 31, | TTM Q2 2022Ended Jun 30, | TTM Q3 2022Ended Sep 30, | TTM Q4 2022Ended Dec 31, | TTM Q1 2023Ended Mar 31, | TTM Q2 2023Ended Jun 30, | TTM Q3 2023Ended Sep 30, | TTM Q4 2023Ended Dec 31, | TTM Q1 2024Ended Mar 31, | TTM Q2 2024Ended Jun 30, | TTM Q3 2024Ended Sep 30, | TTM Q4 2024Ended Dec 31, | TTM Q1 2025Ended Mar 31, | TTM Q2 2025Ended Jun 30, | TTM Q3 2025Ended Sep 30, | TTM Q4 2025Ended Dec 31, | TTM Q1 2026Ended Mar 31, | TTM Q2 2026Ended Jun 30, | TTM Q3 2026Ended Sep 30, |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | ||||||||||||||||||||
| Operating margin | ||||||||||||||||||||
| Net margin | ||||||||||||||||||||
| EBITDA margin | ||||||||||||||||||||
| FCF margin |